Pfizer's New Platform Under Fire: Convenient Services Behind, User Health May Be Swallowed by Digital Divide!
Under the background of deepening the reform of the medical and health system and promoting the strategy of healthy China, Pfizer, the world's leading pharmaceutical company, actively expands its service model and innovates and launches a comprehensive service platform for consumers. The platform is designed to provide convenient telemedicine services to the general public, including assisting users to schedule telemedicine appointments, complete electronic prescription filling, and easily access Pfizer's drug savings programs for COVID-19, migraines, flu and other diseases. At the same time, the platform will also help the public arrange for important vaccination services such as pneumococcal pneumonia vaccine and respiratory syncytial virus vaccine.
Amir Malik, Pfizer's Chief Commercial Officer in the United States, stressed that the launch of the platform is an important step in the company's commitment to simplifying access to health care for people seeking a better and healthier life. Pfizer will continue to deepen collaboration with partners such as Upscript Thealth, Alto Pharmacy and Instacart to build a better healthcare delivery system.
It is worth mentioning that Pfizer has a wealth of experience in the field of pharmaceutical services, as early as 2011, its flagship product Lipitor cholesterol drug has launched mail order services to meet market demand. Going forward, Pfizer will further expand its service capabilities, but at this stage it will focus on providing convenient same-day appointments, whether online or offline, and ensuring timely distribution of medicines and diagnostic tests for diseases such as COVID-19 and influenza. The medicines will be delivered by Courier to the designated pharmacy or to the user.
In addition, the PfizerForAll platform will integrate all of Pfizer's drug savings plans to provide consumers with a one-stop service experience to help the general public more easily enjoy their own health benefits, thereby effectively improving the level of public health.
Looking for chemical products? Let suppliers reach out to you!
2026-06-23
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA Approves Datopotamab Deruxtecan for Second Indication 45 Percent Response Rate in EGFR Mutant Lung Cancer
-
UK Parliament Approves Assisted Dying Bill 7500 Could Seek Euthanasia Annually
-
4 Pharma Firms Lose Licenses in Jammu and Kashmir Amid Illegal Drug Sales Crackdown
-
Over 100 Foreign Pharma Executives Join Chinese Firms in 5 Years Industry Faces Key Challenges
-
Merck’s New CMV Drug Approved in China Targets Nearly 40000 HSCT Patients
-
Trump Warns of 200 Percent Tariffs on Pharma Companies by August 1 India Trade Deal Among Top Priorities
-
Emcure Seals Exclusive Deal for Sanofi’s Oral Diabetes Brands Millions of Indian Patients to Benefit
-
AstraZeneca Rare Disease Drug Misses Phase 3 Target Hope Shifts to Subgroup Data
-
Over 22,000 New Cases in India AstraZeneca Gets CDSCO Green Light for Muscle-Invasive Bladder Cancer Drug
-
60 Percent Workforce Held by Top 10 Firms! China’s TCM Industry Faces Fierce Reshuffle as Private Leaders Expand Fast
Recommend Reading
-
₹27,548 Crore Pharma Giant Cipla Enters Weight Management Battle as Obesity Demand Surges
-
Roche Keeps German Diagnostics Investment
-
Pfizer Warns Germany Over Drug-Pricing Policy
-
India Raises Cancer Drug Price Caps by 50%
-
West Asia’s Conflict Is Testing the Hidden Fragility of Pharma Trade
-
Bodo Möller Chemie Acquires Specialty Chemicals Distributor Quitec
-
January Maleic Anhydride Prices Overall Increased in China
-
KANSAI HELIOS Expands into North America with Acquisition of Advanced Powder Coating Facility in Ohio
-
January China's bunker fuel market fluctuates
-
Eigenmann & Veronelli to Distribute Evolved by Nature Bioactive Peptides in Italy, Spain and Portugal